For people living with HIV, modern treatments have dramatically extended lifespans, transforming the illness from a near-certain death sentence to a manageable chronic condition. But as this population ages, a new set of health challenges is emerging, mirroring those faced by the general public: heart disease, cancer, and chronic lung disease. A significant, and often overlooked, contributor to these risks is tobacco use. Addressing this issue is becoming increasingly critical, and researchers are exploring new ways to integrate effective tobacco treatment directly into HIV care.
The intersection of HIV and tobacco use is particularly concerning. Individuals with HIV are estimated to smoke at a significantly higher rate—around 49%—than the general population, which currently stands at approximately 11.5% according to the Centers for Disease Control and Prevention . This disparity isn’t accidental; nicotine can interact with HIV medications, and the stress and mental health challenges often associated with an HIV diagnosis can contribute to smoking initiation or continuation. Successfully tackling integrating tobacco treatment in HIV care is therefore a vital component of comprehensive patient wellbeing.
A Team-Based Approach to Breaking the Cycle
E. Jennifer Edelman, MD, MHS, a professor of medicine (general medicine) at Yale School of Medicine (YSM), has dedicated years to studying this complex relationship. Her research focuses on optimizing HIV prevention and treatment in the context of substance use, including tobacco. Dr. Edelman, certified as an internist, HIV specialist and in Addiction Medicine, serves as an HIV provider and the physician consultant in the Addiction Medicine Treatment Program at the Yale New Haven Hospital Nathan Smith HIV Clinic.
In a study published in JAMA Network Open, Dr. Edelman, along with Steven L. Bernstein, MD, of the Geisel School of Medicine at Dartmouth, and other collaborators, tested an adaptive, team-based strategy to improve tobacco treatment within HIV clinics . The research highlighted the need for flexibility and a collaborative approach, recognizing that a one-size-fits-all model often falls short.
“What we found is that a more adaptive approach, where the team—including physicians, nurses, social workers, and peer support specialists—can tailor the intervention to the individual patient’s needs and readiness to quit, is more effective,” explains Dr. Edelman. “It’s about meeting patients where they are and providing the support they need, when they need it.”
Beyond the Patch: Tailoring Interventions for Success
Traditional tobacco cessation methods, such as nicotine replacement therapy (patches, gum, lozenges) and counseling, can be helpful, but they aren’t always sufficient for individuals with HIV. The study emphasized the importance of considering factors like co-occurring mental health conditions, substance use disorders, and the social determinants of health that can impact a person’s ability to quit.
The adaptive strategy tested by Dr. Edelman and her team involved a stepped-care approach. Patients were initially offered brief advice and self-help materials. Those who weren’t ready to quit immediately were offered more intensive interventions, such as individual counseling, group therapy, or pharmacotherapy. The team also incorporated motivational interviewing techniques to help patients explore their ambivalence about quitting and build their confidence.
Addressing the Unique Challenges of HIV and Tobacco
The research also acknowledged the unique challenges faced by people living with HIV. Smoking can exacerbate the effects of HIV on the immune system, increasing the risk of opportunistic infections and other complications. Some HIV medications can increase nicotine cravings, making it even harder to quit.
“We need to recognize that quitting smoking isn’t just about nicotine addiction,” Dr. Edelman emphasizes. “It’s about addressing the underlying factors that contribute to tobacco use, such as stress, depression, and social isolation. And it’s about providing patients with the resources and support they need to overcome these challenges.”
Looking Ahead: Expanding Access to Comprehensive Care
The findings from Dr. Edelman’s study have important implications for HIV care providers. Integrating tobacco treatment into routine HIV care can significantly improve patient outcomes, reducing the risk of smoking-related illnesses and extending lives. Yet, implementing these changes requires a commitment to training healthcare professionals, allocating resources, and addressing systemic barriers to care.
Dr. Edelman’s work also extends to understanding harms associated with opioid use among people with HIV and collaborating with community-based and public health partners to promote HIV prevention, including the use of pre-exposure prophylaxis (PrEP). She is also Associate Director of the Research on Addiction Medicine Scholars (RAMS) Program and co-Director of Education at the Yale Center for Clinical Investigation, demonstrating a commitment to training the next generation of researchers, and clinicians.
The next step, according to Dr. Edelman, is to scale up these interventions and produce them more widely available. This will require collaboration between healthcare providers, public health agencies, and community organizations. It also requires continued research to identify the most effective strategies for reaching and supporting individuals with HIV who want to quit smoking.
This research underscores the importance of a holistic approach to HIV care, one that addresses not only the medical aspects of the disease but also the social, behavioral, and emotional factors that impact a person’s overall health and well-being.
Do you have experience with tobacco cessation programs? Share your thoughts in the comments below, and please share this article with your network.
